C2 Treatment of Tumor Necrosis Factor Mediated Diseases

Date:: 1996-2000

Reference:: SA/KET/A/4/3/3

Part of:: The Kennedy Trust for Rheumatology Research

Archives and manuscripts

Collection contents

The Kennedy Trust for Rheumatology ResearchSA/KET
- Drug DevelopmentSA/KET/A
  - PatentsSA/KET/A/4
    - Category C Owned by The Kennedy Institute Tied to Licensing Agreement With CentocorSA/KET/A/4/3
      - C2 Treatment of Tumor Necrosis Factor Mediated DiseasesSA/KET/A/4/3/3

About this work

Description

Item relates to patent C2 "Treatment of Tumor Necrosis Factor Mediated Diseases," invented by Marc Feldmann, Ravinder Maini and Richard Williams under applicant The Kennedy Institute of Rheumatology.

The item contains papers relating to the filing and prosecution progress for the U.S. and international applications.

See related material for C2 Espacenet listing (includes patent abstract and digital copies of application).

Publication/Creation

1996-2000

Physical description

1 file (in 2 parts)

Related material

Patent link

Terms of use

This item requires facilitated access. Email library@wellcomecollection.org to request an appointment.

Where to find it

Location Status Access
Closed stores
By appointment Manual request

Location	Status	Access
Closed stores	By appointment	Manual request

Permanent link

Page URL

Wellcome uses cookies.